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ABSTRACT 
Background: Primary dysmenorrhoea is most prevailing symptom in young adolescent girls. It can 
start before menarche and may be present continuously for years even after the patient get married 
and have children. 
Kashtartava can be expressed as- “kashten munchyati iti kastartava” i.e. the condition where Artava is 
shaded with great difficulty and pain is termed as “Kashtarava”. Kashtartava is mentioned as a specific 
symptom in Vatala, Paripluta, Udavartini Yonivyapad, Vataja Artava Dusti, Kshina Artava-Dusti And 
Asrigdar and the diseases in which whole symptomatology denotes Kashtartava, are Pittala, 
Sannipataki, Suchimukhi Yonivyapada and Artavakshaya. 
Aims and objectives: To compare and evaluate the efficacy and safety of Kumaryasava with 
Rajahpravartani Vati in the patients suffering from Prathmik- Kashtartava.  
Material and methods: A prospective open label study was carried out at OPD of Prasuti –Tantra and 
Stri Roga department. 76 patients satisfying the selection criteria were enrolled, however data of fifty 
patients was used for analysis and comparative study. 50 patents were divided into two groups (A and 
B) with twenty five patients in each. Patients of group A were administered Kumaryasava 20 ml with 
equal amount of water and that of group B were administered tab Rajahpravartini vati (125 mg) 2BD 
after meal with normal water before 7 days of menses and during menstrual cycle. Total duration of 
course of medicine was 3 consecutive cycles. Follow-up was done at every menstrual cycle during the 
treatment and follow- up without treatment was done for next three cycles. Assessment of intensity of 
pain was done by VAS and VMSS according to the memory and presentation of the patient. The pain 
was assessed at baseline and at every menstrual cycle.  
Results: After three month of treatment, in both groups the baseline pain was found to be improved in 
every cycle But when the overall result was observed highly significant results were found in group B 
in comparison to group A. The effect of Kumaryasava on associated symptoms was found to be more 
than Rajahpravartini vati. 
Conclusion: Kumaryasava and Rajahpravartani Vati administered in cases of dysmenorrhea in above 
mentioned doses were found safe and effective in pain but Rajahapravartini Vati showed more effect 
on overall symptoms of dysmenorrhea including pain and menstrual pattern though Kumaryasava 
was found to be more effective in associated sign and symptoms of dysmenorrhea. 
KEYWORDS: Praathmika Kashtartava, Rajapravartani Vati, Kumaryasava. 
INTRODUCTION
 The term Kashtartava is made of two words 
Kashta and Artava. Kashtena - with great difficulty. Thus 
the word Kashtartava can be expressed as:- 
“Kashthenamuchyatiiti Kashtartava” i.e. the condition 
where Artava is shaded with great difficulty and pain is 
termed as “Kashtartava”.1 
Artava:- A substance of the body which flow out from 
Apatya marga at the specific period of time, without 
pain, burning and sliminess is called as Artava.  
 In Ayurvedic classics all gynaecological 
problems are described under the umbrella of 
Yonivyapada. The disease ‘Kashtartava’ is not described 
in classics as well as in Vedas as an individual disease 
entity. Though it is a symptom of various Yonivapadas 
specially Udavartini2, Vatala, Sannipatika etc. 
Kashtartava is a Tridoshajavyadhi with Vata 
predominance. There is dearrangement of Apana and 
Vyana Vayu along with vitiation of Rasa Dhatu. 
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Kashtartava can be compared with dysmenorrhea on 
the basis of its signs and symptoms. 
 According to Ayurveda, due to movement of 
natural urges in reverse direction, the aggravated 
Apana Vayu moving in reverse direction fills the uterus. 
The uterus seized with pain, initially throws or pushes 
the Raja (menstrual blood) upwards, then discharges it 
with spasmodic pain. Ayurveda also describes Vataja 
Yonivapad in which Ras Dhatukshaya creates general 
weakness and cause oligomenorrhoea associated with 
dysmenorrhoea. When we go through all the conditions, 
Samanya Nidan (the general etiological factors) of 
Kashtartava are found as Mithya Ahar-Vihar, Artava and 
Bija Dusti, Daiva-Prakop6, Vishamasanshayan, use of 
Apdravyas7. Vishishta-Nidan (Specific main etiological 
factors) can be described with the help of Nidanas given 
for particular disease conditions. The Samprapti 
(pathogenesis) of Kashtartava explained that all the 
three Doshas are involved with predominance of Vata 
Dosha.  
 According to Acharya Charak (there are three 
causes of Vata Vriddi-Dhatu Kshaya, Doshprakop, 
Margavrodh.8 
 Due to Anuloma Dhatu Kshaya, resulting from 
Vata Vardhak Aharvihar, Artavkshaya occurs as Artava 
is Updhatu of Ras Dhatu.9 Yonivedana is the cardinal sign 
of Artavkshaya. Apart from that Dhatukshaya may turns 
woman to be Heen Satva, where the pain threshold is 
very less and mild pain is felt very severe.10 
 Dosh Prakopa can be occur in two ways Swa-
Dhatuvaishamya and Unmarg-Gaman,11 Acharya 
Charaka says that by occupying different seats, vitiated 
Vata produces various disorders with respect to its 
various etiological factors. This vitiated Vata by its 
Ruksh, Sheet, Sukshma properties spread through 
Rasavaha and Raktavaha Srotus and further it is 
responsible for Artavaha Srotodusti. Dosh-Dushya 
sammurchchhana takes place in the Garbhashaya. Here 
due to vitiation of Vyaana and Apaana vayu the normal 
Aakunchana and Prasaarana kriya of Garbhashaya is 
affected, which will hinder the normal flow of 
Vahipushpa, resulting in Kashtartava, e.g. in Vataj 
Yonivyapada and Vataj Artavdusti. In case of Udavartini 
Yonivyapada the functions of Apaan vayu gets altered 
due to Urdhvagaman and causes pain. 
 “Dosha Avrita Margatvata Artavam Nashyati 
Striyah”12. Dalhana has explained that the vitiated 
Doshas are Vata and Kapha individually and in 
combined form. In case of Kaphaavrit Vyaan pain is an 
additional symptom which has been stated by Vangsen 
and Hansrajnidan. The vitiated Kapha due its Snigdha, 
Guru, Pichchhila and Abhishyandi gunas will cause 
Jatharagni and Dhatvagni Mandya and that will produce 
Ama. This Ama Dhatu causes Uplepa over the Artav-
Vaha Srotas which leads to Artavapravritti - Avarodh 
and Kastartava. 
 Mansik bhava like Bhaya, Shoka, Chinta, Krodha, 
Tanava also aggravates the Vata resulting in the same 
pathology of Kastartava. Na hi vatadrute shoolam.13 
Vata is the main responsible factor, though other 
Doshas only be present as Anubandhi to it. 
 Dysmenorrhoea is a medical condition of pain 
during menstruation but more realistic definition 
includes cases of sufficient magnitude so as to 
incapacitate daily activities.14 A pain which is of uterine 
origin and directly linked to menstruation but with no 
visible pelvic pathology is called Primary dysmeno-
rrhoea. Pain reaches a maximum between ages of 18 
and 24 years and thereafter diminishes. The pain is 
mainly felt in hypogastrium and is often referred to 
inner and front aspects of the thighs. During a severe 
attack the patient looks drawn and pale and may sweat; 
nausea and vomiting are common; there may be 
diarrhoea and rectal and bladder tenesmus.15 
 Associated complaints of dysmenorrhea were 
recorded on their presence or absence like nausea, 
vomiting, headache, dizziness, fainting attacks, 
constipation or loose motion etc. Amount, colour, 
consistency and frequency of menstrual blood were also 
observed to exclude other pathologies. For the 
assessment of general health screening blood test (HB, 
TLC, DLC, ESR, RBS, Bl. urea), serum test (HIV, VDRL, 
HBsAg, Anti HCV) and urine test (routine and 
microscopic) were done. 
Objectives- To evaluate and compare the efficacy and 
safety of two classical compound Kumaryasava and 
Rajahpravrtani Vati in patients suffering from primary 
dysmenorrhoea. 
MATERIAL AND METHODS 
Study design- The study was a prospective open- label 
single center trial executed at Rishikul Ayurved Campus. 
The study was done in accordance with the good 
practice guidelines of WHO. 
Study participants- Total 70 patient were to be 
enrolled in trial from the OPD of Prasuti Tantra Evam 
Stri Roga department. Patients were screened in 
accordance with the inclusion and exclusion criteria 
mentioned in the protocol. Total 50 patients following 
the screening criteria were recruited in the study after 
obtaining informed written consent. 
Inclusion Criteria - married or unmarried female 
patient aged between 15 and 35 years with average 
general health and having chief complain of 
dysmenorrhoea without any pelvic pathology. The 
range of general screening investigations (blood, serum, 
and urine) of these patients were found to be in normal 
limits and who were willing to participate in the study 
for three months. 
Exclusion Criteria 
 The patients with low general condition, having 
abnormal value of screening investigations were 
excluded from the study.  
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 Patients who were found to have primary 
dysmenorrhoea due to imperforated hymen, 
mullerian duct anomalies like septate, unicornuate 
or bicornuate uterus, hypo plastic uterus etc.  
 Secondary dysmenorrhoea with evidence of any 
type of pelvic pathology (fibroid uterus, ovarian 
cyst, endometriosis, pelvic inflammatory disease 
etc.).  
 Patients having done tubal ligation for permanent 
contraception, patients on contraceptive pills. 
 Patients with evidence of malignancy. 
 Patients suffering from any other major systemic 
illness necessitating long term therapy. Alcoholics 
or drug abusers, lactating women, and patients who 
have the past record of hypersensitivity to any of 
the ingredients of the trial medications were also 
excluded from the study. 
Study intervention – Study medications included in 
group A Kumaryasava 20 ml twice a day after meal with 
equal amount of water and in group B two tablets of 
Rajahpravartani Vati (one tab of 125 mg) twice a day 
with normal water after meal. In both groups the 
medicine was administered before 7 days of the date of 
menstrual cycle. Both Ayurvedic formulations were 
procured from good manufacturing practice -certified 
Ayurvedic pharmaceutical industries and standardised 
following the standard laid in Ayurvedic pharmacopoeia 
of India. Patients were also guided for Pathya- Apathya 
and Yoga (stabilising exercises). 
Study procedure: on the enrollment day at baseline 
(visit 1), patient’s demographic profile, and medical 
history family history, menstrual history (particularly 
related to dysmenorrhoea) obstetric history in married 
patient, patient’s Sharirik Prakriti and vital parameters 
were recorded. Patient’s general, systemic and 
specifically gynaecological, all examinations were done 
and findings were recorded. Subsequent visits were 
planned at the interval of one month or according to the 
last menstrual cycle of the patient i.e. second visit at 
next menstrual cycle or 60th day and third visit at about 
90th day. Patients were assessed and given study 
medications at each subsequent visit till 90th day. The 
patients were further observed for next Three cycles 
without any medicine. At the study site, data of all 
patients were recorded in predesigned case report form 
(CRFs). 
 Out of the total 76 patients enrolled in the 
study, 13 dropped out during the study. Intervention to 
treat analysis was done, and the data of all those 
patients who have completed at least two cycle visit 
were imputed by last observation carried forward 
method (LOCF). Patients who dropped out after 
baseline visit only were excluded from analysis. Hence 
data of 50 patients (which were equally divided in two 
groups i.e. 25 patients in each group) were used for 
statistical analysis.  
Statistical analysis: Symptomatic relief was assessed 
as percentage change in terms of presence of any 
symptom at baseline and at 90th day. Visual analogue 
scale (VAS)16 questions and Verbal multidimensional 
scoring system (VMSS)17 was used to assess the severity 
of dysmenorrhea. The VAS using a 10- cm line 
represented the continuum of the female student's 
opinion of the degree of pain. One extremity of the line 
represented ‘unbearable pain’, and the other extremity 
represented ‘no pain at all’. The participants were asked 
to rate the degree of pain by making a mark on the line. 
The scores received from the scale were classified into 
mild dysmenorrhoea if it was between 1–3 points, 
moderate between 4–7 points, and severe between 8–
10 points. The VMSS system was defined as mild, 
moderate, and severe based on pain and limited 
activities. Associated symptoms and menstrual pattern 
was also observed based on percentage change in no of 
patients. 
Table 1: Verbal multidimensional scoring system (VMSS) for assessment of dysmenorrhoea severity 
Severity grading Working 
ability 
Systemic 
symptoms 
Analgesics 
Grade 0: Menstruation is not painful and daily activity is 
unaffected. 
Unaffected None None 
required 
Mild (Grade 1): Menstruation is painful but seldom inhibits 
normal activity; analgesics are seldom Required; mild pain. 
Rarely 
affected 
None Rarely 
required 
Moderate (Grade 2): Daily activity is affected; Analgesics 
required and give sufficient relief so that absence from school is 
unusual; moderate pain. 
Moderately 
affected 
Few Required 
Severe (Grade 3): Activity clearly inhibited; poor effect of 
analgesics; vegetative symptoms (headache, Fatigue, vomiting, 
and diarrhoea); severe pain. 
Clearly 
inhibited 
Apparent Poor effect 
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OBSERVATIONS AND RESULTS 
 Data of total 50 patients were subjected to statistical analysis. Out of these maximum patients were in age 
group of 17-20 years. i.e. Madhyama Awastha (28% in group A and 24% in group B ) and maximum were unmarried 
(68% in both groups). The Prakriti of maximum patients was found to be Vata-Pittaja in both groups I.e. 28% in 
group A and 32% in group B. The demographic profile of the patients in both the groups is given below in (Table 1). 
Table – 2. Demographic profile (n = 50) values are expressed in n(%) 
 Age group in years (Acharya Harita) GRP- A Kumaryasava GRP-B Rajahpravartini vati 
 n=25 n=25 
10-11 (Bala) early age of menarche 2 (8%) 1 (4%) 
12 (Rajaswala) menarcheal age 1 (4%) 1 (4%) 
13-14 (Bala) average age of menarche 3 (12%) 3 (12%) 
15-16 (Bala) delayed age of menarche 4 (16%) 5 (20%) 
17- 20 (Madhyam-Awastha) 7 (28%) 6(24%) 
21- 24,, 4 (16%) 4 (16%) 
25-28,, 3 (12%) 2 (8%) 
29-32,, 2 (8%) 1 (4%) 
33-36,, 0 1 (4%) 
37 (end of Uttama-awastha) end of best age of fertility 0 1 (4%) 
Sex – all female   
Marital status   
Married 8 (32%) 8 (32%) 
Unmarried 17 (68%) 17(68%) 
Educational status   
Illiterate 1 (4%) 1 (4%) 
Read and write 24 (96%) 24 (96%) 
Occupation   
Student 13 (52%) 15 (32%) 
Working 8 (32%) 8 (32%) 
Housewife 4 (16%) 2 (8%) 
Socioeconomic status   
Above poverty line 14 (56%) 15 (56%) 
Below poverty line 11 (44%) 10 (40%) 
Habitat   
Urban 10 (40%) 10 (40%) 
Semi-urban 10(40%) 10 (40%) 
Rural 05 (20%) 05 (20%) 
Sharirik Prakriti   
Vataja 07 (28%) 08 (32%) 
Pittaja 05 (20%) 05 (20%) 
Kaphaja 00 00 
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Vata-pittaja 06 (24%) 06 (24%) 
Vata-kaphaja 05 (20%) 05 (20%) 
Pitta-kaphaja 00 00 
Sannipataja 02 (8%) 01 (4%) 
 
 
Fig 1. Pie chart for Sharirik Prakriti in both the groups 
Among the married patients which were 32% in both groups maximum patients were nulliparous 5% in group a and 
37.5 % in group B. 87.5% patients in group A and 75% % in group B were having the history of abortions. (Table 3) 
Table -3-Distribution of patients according to the obstetric history in married patients 
 GRP-A GRP-B 
Parity n=8 n=8 
 0 04 (50%) 3 (37.5%) 
 1 02(25%) 02(25%) 
 2 01 (12.5%) 01(12.5%) 
 3 00 01(12.5%) 
>3 01(12.5%) 01 (12.5%) 
Abortions   
 Present 07 (87.5%) 06 (75%) 
Absent 01(12.5% ) 01(12.5%) 
Contraception   
Present (only on barrier methods) 04(50%) 04(50%) 
Absent 04(50%) 04(50%) 
Regarding the pattern of menstruation it was observed that 32% patients in both groups were having duration of 5-6 
days with 25-27 days interval. Amount of bleeding was moderate (5-6 pads /day) in 56% patients in group A and 
76% patients in group B. The pain was found in lower back & lower abdomen in 56% patients in group A and 52% in 
group B. According to visual analogue scale the pain was of moderate type in maximum patients of both the groups 
(52% of patients). (Table 4) 
 
28%
20%
0%
24%
20%
0%
8%
Group  A
vataja pittaja kaphaja
vat -pittaja vata kaphaja pitta kaphaja
sannipataja
32%
20%
0%
24%
20%
0% 4%
Group  B
vataja pittaja kaphaja
vat -pittaja vata kaphaja pitta kaphaja
sannipataja
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Table-4-Distribution of patients according to pattern of menstrual cycle —values are expressed in mean 
(standard deviation) 
Duration GRP-A GRP-B 
3-4 04 (16%) 05(20%) 
4-5 06(24%) 06(24%) 
5-6 08(32%) 08(32%) 
6-7 07 (28%) 06(24%) 
Interval   
25-27days 08(32%) 09(36%) 
28-30 04(16%) 04(16%) 
31-33 06 (24%) 06(24%) 
33-35 07(28%) 06(24%) 
Amount of blood   
Normal 3-4 pads in24 hrs 11(44%) 06(24%) 
Moderate 5-6 pads 14(56%) 19 (76%) 
Colour of blood    
Blackish red 11(44%) 06(24%) 
Brownish red 14(56%) 19(76%) 
Consistency of blood   
Thick mucoid 08(56%) 05(20%) 
Clotted 10(40%) 10 (40%) 
Normal 07 (28%) 10(40%) 
Onset of pain   
Before7 days up to menses 11 (44%) 11 (44%) 
Before 6-5 05(20%) 04(16%) 
Before 4-3 04(16%) 04(16%) 
Before 2-days 02 (8%) 03(12%) 
On first day 03 (12%) 03(12%) 
Site of pain   
Low back 03(12%) 03(12%) 
Lower abdomen 08(32%) 09 (36%) 
Low back and lower abdomen 14 (56%) 13 (52%) 
Radiation of pain   
Medial aspect of thighs 22 (88%) 20 (80%) 
Leg 03 (12%) 05 (20%) 
Severity of pain (according to VAS)   
Mild 04 (16%) 04(16%) 
Moderate 13(52%) 13(52%) 
Severe 08 (32%) 08 (32%) 
Nature of pain   
Pricking 02 (8%) 3 (12%) 
Spasmodic with pricking 09 (36%) 09 (36%) 
Colicky 14 (56%) 13(52%) 
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Duration of pain   
Intermittent (stay upto 1-2 min) 09 (36%) 09(36%) 
Continuous(didn't relieved without intervention) 16(64%) 16 (64%) 
Aggravating factor not relevant   
Relieving factors    
 anti-spasmodic or analgesics    
 (More frequent dose with injectable) 16(64%) 16(64%) 
 With normal doses 09(36%) 09(36%) 
On gynaecological examination it was found that maximum patients were with healthy cervix without any 
congestion and abnormal discharges in both the groups (32% of the patients). 
Rectal examination was done in unmarried patients to assess the position of the uterus. It was found that maximum 
patients were having normal sized anteverted uterus. (Table 5) 
Table-5- Distribution of patients according to gynaecological examination 
Per speculum examination in married patients (n=8) GRP-A GRP-B 
   
Healthy cervix without any congestion and abnormal discharges  06(75%) 06(75%) 
Healthy cervix with mild hypertrophy and mild watery discharges  02(25%) 02(25%) 
Per vaginal examination in married patients (n=8)   
AV nulliparous uterus with non-tender fornix 02(25%) 02(25%) 
AV normal size uterus with non-tender fornix 02(25%) 02(25%) 
AV parous size uterus with non-tender fornix 02(25%) 02(25%) 
RV normal size uterus with non-tender fornix 02(25%) 02(25%) 
Per rectal examination in un-married patients    
AV normal size uterus 13(16.25%) 13(16.25%) 
RV 04(50%) 04(50%) 
Table - 6 Distribution of patients according physical parameters 
Parameters Group A  Group B 
Height (m)   
 4ft-4.5ft 08(32%) 08 (32%) 
 4.6ft -5.5 ft 17(68%) 17 (68%) 
Weight ( kg )   
45-50 07(28%) 07(28%) 
51-55 10(40%) 10(40%) 
56-60 05(20%) 05(20%) 
61-65 03(12%) 03(12%) 
Respiratory rate (per minute)   
15-16 06(24%) 06(24%) 
17-18 09(36%) 09(36%) 
19-20 03(12%) 02(08%) 
21-22 02(08%) 03(12%) 
Pulse rate (per minute)   
60-70 05(20%) 05(20%) 
71-80 09(36%) 08(56%) 
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81-90 16(64%) 17(68%) 
Blood pressure (mm Hg)   
Systolic   
90-100 08(32%) 07(28%) 
101-110 08(32%) 09(36%) 
111-120 06(24%) 07(28%) 
121-130 03(12%) 02 (08%) 
Diastolic   
60-70 10(40%) 10(40%) 
71-80 12(48%) 11(44%) 
81-90  03(12%) 04(16%) 
Table-7 Distribution of patients according to laboratory parameters—values are expressed in mean 
Parameters Group A Group B 
Hb% 10.8 gm\dl 11.4 gm\dl 
TLC 3200.00 cells\cumm 3600.00 cells\cumm 
DLC   
Polymorphs 52 % 50 % 
Leucocytes 42% 38% 
Eosinophyls 2 % 2 % 
Monocytes 4 % 4 % 
ESR 16 18 
Bl sugar 98 gm\dl 76 gm\dl 
Liver profile   
Sr total bilirubin 0.10 mg\dl 0.30 mg\dl 
SGOT 0.20 mg\dl 0.25mg\dl 
SGPT 34.00 mg \dl 36.00 mg \dl 
Sr albumin 7.30 g\dl 6.40 g\dl 
Sr globulin 4.20 g\dl 3.5 g\dl 
Sr alkaline phosphatase 200.00 U\L 170.00 U\L 
Kidney profile   
Bl urea 20.8 19.4 
Sr creatinine 0.8 0.8 
Sr uric acid 3.7 3.6 
Table - 8 Effect of treatment on severity of dysmenorrhea according to the verbal multidimensional scoring 
system (VMSS) in group A and group B 
 Group A Group B 
 
Grading 
Baseline 
(BT) 
After 
treatment 
Following 
treatment 
Baseline 
(BT) 
After 
treatment 
Following 
treatment 
Mild  5 (20%) 19(56%) 15(60%) 6(24%) 18(72%) 18(72%) 
Moderate  12(48%) 4(16%) 7(28%) 14(56%) 6(24%) 5(20%) 
Severe 8(32%) 2(8%) 3(12%) 5(20%) 1(4%) 2(8%) 
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Fig 2. Effect of treatment on severity of dysmenorrhea according to the verbal multidimensional scoring 
system (VMSS) in group A and group B 
Effect of treatment on important characteristics of dysmenorrhea in group A and group B (Table 9) Onset In 
relation with menstruation when pain starts  
 In group A (Kumaryasava) initially 40% 
patients were having onset of pain before 12 hours 
which reduced to only 12 % after treatment and 
following treatment. Thus after completion of treatment 
and following treatment most of the patients were 
having pain only just 4-1 hours before the onset of 
menstruation. 
 In group B (Rajahpravartini Vati )initially 36% 
patients were having onset of pain before 12 hours 
which reduced to only 16 % after treatment and 
following treatment and after completion of treatment 
and following treatment maximum patients were 
having pain 4-1 hours of onset of menstruation. 
 Thus it was found that group B patients 
(Rajahpravartini Vati) were having more relief in the 
onset of pain regarding to menstruation (1-4 hours 
after the onset of menstruation). 
Severity of pain (based on VAS score) 
 In group A (Kumaryasava) maximum patients 
(52%) were having moderate pain according to VAS 
(Visual Analogue Score) which reduced to only 36 % 
after treatment and 28% following treatment. And after 
completion of treatment and following treatment 56% 
patients were having mild pain abdomen only which 
was 16 % before treatment. 
 In group B (Rajahpravartii Vati) 48% patients 
were having moderate pain according to VAS (Visual 
Analogue Score) which reduced to only 20 % after 
treatment and 24% following treatment. And after 
completion of treatment and following treatment 64 % 
patients were having mild pain abdomen only which 
was 16 % before treatment. 
 Thus it was found that group B patients 
(Rajahpravartini Vati) were having more relief in the 
severity of pain as compared to group A (Kumaryasava). 
Type of pain: 64 % patients were having intermittent 
pain initially and following treatment 80% patients 
were having intermittent type of pain in group A 
Effect was found in continuous pain abdomen in group 
A in 16 % of patients (36 % before treatment and 20 % 
following treatment).  
 In group B 32 % patients were having 
continuous pain abdomen which was found to be in 24 
% patients following treatment. Effect of the drug was 
found only in 8 % patients on type of pain. 
 Thus more effect was found in group A 
(Kumaryasava) on changing the type of pain to 
intermittent type from continuous pain. 
Duration (for how many days the pain persists) 
 In group A (Kumaryasava) maximum patients 
(64%) were having pain residing for duration of 1-
2days initially which was further reduced to only 12 % 
of patients after treatment and following treatment. 
After completion of treatment maximum patients were 
having pain residing for < 1 days only. Changes were 
observed in 48 % of patients in reducing the duration of 
the pain to < 1 days.  
 In group B (Rajahpravartini Vati) 56 % of 
patients were having pain residing for duration of 1-2 
days initially which was further reduced to only 16 % of 
patients after treatment and following treatment. After 
completion of treatment maximum patients (64 %) 
were having pain residing for < 1 days only. Changes 
were observed in 52 % of patients in reducing the 
duration of the pain to < 1 days.  
 Thus more effect was found in group B 
(Rajahpravartini vati) on reducing the duration of pain.  
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Table 9. Effect of treatment on important characteristics of dysmenorrhea in group A and group B 
Characteristics Group A Group B 
 Before 
treatment 
After 
treatment 
Following 
treatment 
Before 
treatment 
After 
treatment 
Following 
treatment 
Onset In relation with 
menstruation when pain starts 
      
Before 12 hours  10(40%) 3(12%) 3(12%) 9(36%) 4(16%) 4 (16%) 
Before 12-9 hours 7(28%) 4(16%) 4(16%) 6(24%) 5(20%) 5(20%) 
Before 8-4 hours 4(16%) 4(16%) 4(16%) 3(12%) 1(4%) 1(4%) 
Before 4-1 hours 3(12%) 6(24%) 7(28%) 4(16%) 13(52%) 13(52%) 
After 1-4 hours  1(4%) 8(32%) 7(28%) 1(4%) 2(8%) 2(8%) 
Severity of pain 
(based on VAS score) 
      
Mild (1-3) 04 (16%) 14(56%) 14(16%) 4(16%) 16(64%) 15(60%) 
Moderate (4-7) 13(52%) 9(36%) 7(28%) 12(48%) 5(20%) 6(24%) 
Severe (8-10) 08(32%) 2(8%) 4(16%) 09(36%) 4(16%) 4(16%) 
Type of pain       
Intermittent (stay upto 1-2 min) 16(64%) 20(80%) 20(80%) 17(68%) 19(76%) 19(76%) 
Continuous (didn't relieved  
without intervention) 
09(36%) 5(20%) 5(20%) 8(32%) 6(24%) 6(24%) 
Duration (for how many days  
the pain persists) 
      
<1 day 2(8%) 14(56%) 13(52%) 3(12%) 16(64%) 15(60%) 
1 day 3(12%) 4(16%) 5(20%) 2(8%) 3(12%) 4(16%) 
1-2 days 16 3(12%) 3(12%) 14(56%) 4(16%) 4(16%) 
2-4 days 2(8%) 3(12%) 3(12%) 3(12%) 1(4%) 1(4%) 
> 4 days 2(8%) 1(4%) 1(4%) 3(12%) 1(4%) 1(4%) 
Effect of treatment on associated sign and 
symptoms of dysmenorrhea in group A and group B 
(Table 10) 
Fever: 60% patients were having associated complaint 
of fever initially but only 20% and 24% patients were 
having the complaint of fever after treatment and 
following treatment respectively in group A. 
In group B 60% patients were having associated 
complaint of fever initially but only 36% and 40 % 
patients were having the complaint of fever after 
treatment and following treatment respectively.  
The difference obtained is more in group A 
(Kumaryasava) thus Kumaryasava is greater effect than 
Rajahpravartini vati on fever. 
Anorexia: Severe anorexia was found in 40% of 
patients before treatment in group A which was 
reduced to only 8 % patients following treatment. 
Maximum patients (60 %) were having mild anorexia 
only following treatment. 
In group B also 40% of patients were having severe 
anorexia initially but it was improved only in 16% of 
patients i.e., 24 % of patients were still having severe 
anorexia following treatment. The difference obtained 
and the improvement was better in group A, thus 
Kumaryasava showed more effect on anorexia. 
Nausea: In group A the improvement in nausea was 
found to be in 16% of patients after treatment while in 
group B only 9 % of patients showed absence of nausea 
after treatment. Thus in nausea also Kumaryasava 
worked better than Rajahpravartini vati. 
Vomiting : Though maximum patients (52 %) were 
having only mild vomiting before treatment in group A 
the effect of the drug was obtained on person having 
moderate vomiting before treatment. Only 20 % of 
patients were having moderate vomiting following 
treatment which was found in 48% earlier. 
In group B 28 % of patients were having moderate 
vomiting initially and the difference was obtained only 
8% of patients. 
The result obtained was better in group A as the effect 
was found in 28 % of the patients. 
Headache: The improvement in headache was found in 
32% of patients in group A after treatment while in 
group B only 20 % of patients showed reduction in 
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complaint of headache. Thus in headache also 
Kumaryasava worked better than Rajahpravartini Vati. 
Dizziness: Dizziness was found in 48% of patients 
before treatment in group A which was reduced to 32 % 
patients following treatment. Maximum patients (68 %) 
were having absence of dizziness following treatment. 
In group B also 48% of patients were having dizziness 
initially but it was found only in 24% of patients after 
treatment and reduced further to 16% of patients 
following treatment. 
Though the effect of the drug was found more in group 
A it was noticeable that Rajahapravartini Vati have 
greater effect on reducing the symptom following 
treatment. 
Fainting attacks: The improvement in fainting attacks 
was found in 12% of patients in group A after treatment 
while in group B only 4 % of patients showed reduction 
in complaint of fainting attacks. Thus in fainting attacks 
Kumaryasava worked better than Rajahpravartini Vati. 
Bowel disturbances : marked improvement was found 
in group A (36 % of the patients) after treatment while 
in group B changes in bowel disturbances was 
improved in only 28% of the patients which was less 
than improvement of group A 
Table 10 Effect of treatment on associated sign and symptoms of dysmenorrhea in group A and group B 
 Group A Group B 
 Before 
treatment 
After 
treatment 
Following 
treatment 
Before 
treatment 
After 
treatment 
Following 
treatment 
Fever       
Present occasionally 
 (temp 99-100)  
15(60%) 5(20%) 06(24%) 15(60%) 9(36%) 10 (40%) 
Absent 10(40%) 20 (80%) 19(76%) 10(40%) 16(64%) 15(60%) 
Anorexia       
Mild 06(24%) 15(60% 15(60% 06 (24%) 09(36%) 09(36%) 
Moderate 09 (36%) 8(32%) 8(32%) 09(36%) 10 (40%) 10 (40%) 
Severe 10(40%) 2 (8%) 2(8%) 10 (40%) 06(24%) 16 (64%) 
Nausea       
Present 19 (76%) 03(12%) 03(12%) 19(76%) 10(40%) 11(44 %) 
Absent 06(24%) 22(88%) 22 (88%) 06 (24%) 15 (60%) 14 (56%) 
Vomiting       
Mild 13 (52%) 20 (80%) 21(84%) 18(72%) 20 (80%) 21 (84%) 
Moderate 12(48%) 5 (20%) 4 (16%) 07(28%) 5 (20%) 4 (16%) 
Headache       
Mild 14(56%) 22 (88%) 22(88%) 15(60%) 20 (80%) 20 (80%) 
Moderate 11 (44%) 3(12%) 3(12%) 10 (40%) 5 (20%) 5()20% 
Dizziness       
Present 12 (48%) 8 (32%) 10 (40%) 12 (48%) 6 (24%) 4 (16%) 
Absent 13(52%) 17 (68%) 15 (60%) 13 (52%) 19 (76%) 21 (84%) 
Fainting attacks       
Present 07 4 (16%) 19 (76%) 5 (20%) 6 (24%) 6 (24% ) 
Absence 18(72%) 21(84%) 6(24%) 20(80%) 19 (76%) 19 (76%) 
Bowel disturbances       
 Not present  12 (48%)  21 (84%) 22 (88%) 12 (48%) 5 (20%) 5 (20%) 
 Present  13 (52%) 4 (16%) 3 (12%) 13 (52%) 20 (80%) 20 (80%) 
Duration: no significant changes were obtained in both the groups regarding the duration of menstruation. 
Interval: no significant changes were obtained in both the groups regarding the interval of menstruation. 
Amount of blood: Initially in group a 28% patients were having scanty bleeding during menses and after treatment 
20 % were patients were found with scanty bleeding. Only 8 % of patients showed improvement in bleeding per 
vaginum, thus Kumaryasava have mild effect on improving in the quantity of bleeding. 
In group B 28% patients were having scanty bleeding during menses before treatment and after treatment it was 
found in only 16 % of the patients. Improvement was found in 24 % of the patients, thus showing that 
Rajahpravartini Vati have greater effect on improving amount of bleeding. 
Int. J. Ayur. Pharma Research, 2017;5(11):1-13 
     Available online at: http://ijapr.in  12 
Colour of blood: in group A 60 % patients were having blackish color of menstrual blood initially and after 
treatment only 16 % patients remained with blackish color. 
In group B initially 24 % were having blackish color of menstrual blood which was found in only 12 % patients after 
treatment. Thus Kumaryasava showing more effect on improving the color of blood. 
Consistency of blood: In group A 28 % were having normal consistency of blood before treatment which increased 
to 44 % after and following treatment while in group B initially only 40 % patients were having normal bleeding 
which was further increased to 84 % patients after and following treatment. Changes observed in group A were 16 % 
and in group B were 44 %. Thus group B (Rajahpravartini Vati) showed greater effect on improving the consistency 
of blood. 
Table 11. Effect of treatment on pattern of menstrual cycle 
 Group A Group B 
 Before 
treatment 
After 
treatment 
Following 
treatment 
Before 
treatment 
After 
treatment 
Following 
treatment 
Duration       
3-4 days 04 (16%) 04(16%) 04 (16%) 05(20%) 05 (20%) 05 (20%) 
4-5 days 06 (24%) 06(24%) 06 (24%) 06(24%) 06(24%) 06 (24%) 
5-6 days 08 (32%) 08 (32%) 08 (32%) 08 (32%) 08 (32%) 08 (32%) 
6-7 days 07 (28%) 07 (28%) 07(28%) 06(28%) 06(28%) 06 (28%) 
Interval       
25-27days 08 (32%) 08(32%) 08 (32%) 09 (36%) 09(36%) 09 (36% ) 
28-30 days  04 (16%) 07 (28%) 07 (28%) 04 (36%) 04 (36%) 04 (36%) 
31-33 days 06 (24%) 06 (24%) 06 (24%) 06 (24%) 04(16%) 04 (16%) 
33-35 days 07 (24%) 04 (16%) 04 (16%) 06 (24%) 02 (8%) 02 (8%) 
Amount of blood       
Scanty (<3 pads in 24 hrs) 7(28%) 5 (20%) 5(20%) 10(40%) 4(16%) 4 (16%) 
Normal 3-4 pads in 24 hrs 4 (16%)  6(24%) 6 (24%) 09 (36%) 15 (60%) 15(60%) 
Moderate 5-6 pads 14(56%) 14 (56%) 14 (56%) 06 (24%) 06(24%) 06 (24%) 
Colour of blood       
Blackish red 15 (60%) 4 (16%) 4(16%) 4 (24%) 3(12%) 3(12%) 
Brownish red 8(32%) 7 (56%) 7 (56%) 17 (76%) 4(16%) 4(16%) 
Normal menstrual colour 3 (12%) 14 (56%) 14 (56%) 4 (16%) 18 (72%) 18 (72%) 
Consistency of blood       
Thick mucoid 08 (32%) 08 (32%) 08 (32%) 05 (32%) 2 (8%) 2 (8%) 
Clotted 10 (40%) 6(24%) 6 (24%) 10 (40%) 2 (8%) 2(8%) 
Normal 07 (28%) 11 (44%) 11 (44%) 10 (40%) 21(84%) 21 (84%) 
DISCUSSIONS  
 Dysmenorrhea is the common problem in India 
and most of the patients suffered from severity. Many 
Ayurvedic regimens are described in ancient texts to 
treat dysmenorrhea considering it as Doshik imbalance 
due to multifactorial etiology. The present study has 
been conducted to find out an effective treatment for 
dysmenorrhea. The most common drug in Ayurveda is 
Rajahpravartini Vati prescribed abundantly for 
dysmenorrhea. We conducted a study to compare the 
effects of other drug mentioned in classics i.e., 
Kumaryasava with Rajahpravartini Vati and to see the 
effects of both the drugs on pain based on VAS scale, 
severity on VMSS scale, associated features of 
dysmenorrhea and pattern of menstrual cycle. On 
severity of dysmenorrhea more effects were seen in 
Rajahpravartini group. Kumaryasava showed more 
effects on associated criteria of dysmenorrhea. On 
improving the pattern of menstrual cycle 
Rajahpravartini Vati proved to be more effective. 
CONCLUSION 
 Thus it is concluded that though both the drugs 
worked in dysmenorrhea their effect was found on 
different symptomatology. Kumaryasava worked in 
improving the quality of life physically and mentally 
during the phase of menstruation which was effected by 
pain and can be given in dysmenorrhea associated with 
PMS. Rajahpravartini Vati affected the pattern of 
menstruation more than Kumaryasava and also showed 
more effects on decreasing the severity of pain.  
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